Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preferential binding of the carboxylate form of camptothecin by human serum albumin.

× No keyword cloud information.

23 in total

Review 1. Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors: Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal: Clin Pharmacokinet Date: 2016-03 Impact factor: 6.447

2. Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies.

Authors: Eric X Chen; Gerald Batist; Lillian L Siu; Naeema Bangash; Martha Maclean; Lynn McIntosh; Wilson H Miller; Amit M Oza; Chetan Lathia; Oana Petrenciuc; Lesley Seymour
Journal: Invest New Drugs Date: 2005-10 Impact factor: 3.850

3. Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer.

Authors: Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal: AAPS PharmSciTech Date: 2011-11-22 Impact factor: 3.246

4. Factors affecting the in vivo lactone stability and systemic clearance of the lipophilic camptothecin analogue AR-67.

Authors: Eyob D Adane; Zhiwei Liu; Tian-Xiang Xiang; Bradley D Anderson; Markos Leggas
Journal: Pharm Res Date: 2010-04-29 Impact factor: 4.200

5. Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development.

Authors: D J Adams; L R Morgan
Journal: Curr Med Chem Date: 2011 Impact factor: 4.530

6. Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors.

Authors: Fei Tang; Eleftheria Tsakalozou; Susanne M Arnold; Chee M Ng; Markos Leggas
Journal: Invest New Drugs Date: 2019-02-28 Impact factor: 3.850

7. An HPLC assay for the lipophilic camptothecin analog AR-67 carboxylate and lactone in human whole blood.

Authors: Eleftheria Tsakalozou; Jamie Horn; Mark Leggas
Journal: Biomed Chromatogr Date: 2010-10 Impact factor: 1.902

8. Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.

Authors: Wei Feng; Mavurapu Satyanarayana; Yuan-Chin Tsai; Angela A Liu; Leroy F Liu; Edmond J LaVoie
Journal: Eur J Med Chem Date: 2009-02-20 Impact factor: 6.514

9. Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.

Authors: Vincent J Venditto; Kimberly Allred; Clinton D Allred; Eric E Simanek
Journal: Chem Commun (Camb) Date: 2009-08-11 Impact factor: 6.222

10. A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.

Authors: Susanne M Arnold; John J Rinehart; Eleftheria Tsakalozou; John R Eckardt; Scott Z Fields; Brent J Shelton; Philip A DeSimone; Bryan K Kee; Jeffrey A Moscow; Markos Leggas
Journal: Clin Cancer Res Date: 2010-01-12 Impact factor: 12.531